Introduction
Reflection upon the evaluation of sample size when planning a randomised clinical trial (RCT) is widely recognized as a matter of Good Statistical Practice. Less well known is that observational studies and pilot studies can also benefit from thinking about the required number of patients or animals in the design phase of the study. If the sample size is too small, important treatment differences can easily go undetected. This does not mean, however, that an investigator should enrol as many patients or animals as possible in the study. If the number of patients or animals exceeds the number required, the study will be unnecessarily expensive, prolonged and sometimes unethical. An investigator will have to strike a balance between enrolling sufficient patients or animals to detect relevant treatment effects, but not so many that important resources (patients or animals, time, money, etc.) are wasted.
The statistical concepts that play a role in sample size or power calculations are introduced in section 2. Sections 3, 4 and 5 discuss the determination of sample size for various outcome variables. First, sample size calculations are given for a qualitative, dichotomous outcome variable. Next, sample size calculations are given for a quantitative, continuous outcome variable. And third, sample size calculations are given for a survival outcome or time-to-event type variable. Section 6 addresses the ideas behind Cohen's effect size. Section 7 goes into sequential design and analysis as an efficient alternative for some studies. Section 8 offers some closing remarks and conclusions.
In the following sections we will use the term 'study' both for a RCT and for an observational or pilot study; the term 'patients' is used for reasons of convenience, but can be replaced by animals, plants, tissue samples, etc.
Statistical concepts
In the following sections we assume that there is one primary outcome variable in one or two samples. The case of more than two treatment groups will be discussed briefly in section 8.
Let the treatment difference or effect size to be estimated based on the results of the study be characterized by a parameter δ. The standard reasoning in calculating sample size proceeds as follows. Suppose some statistical test will be performed at the end of the study for the null hypothesis H o : δ = 0, i.e. the treatment difference or effect size equals zero. The quantity α, also called the type I error of a statistical test, is the probability of detecting a significant difference when in reality no difference exists, i.e. it represents the risk of a false positive (FP) result. Usually  α is set at a value of 0.05, one-sided or twosided. Next one has to choose a value δ 0  , the smallest value of the treatment effect that
should not go undetected. In other words, if δ 0 is the true treatment effect, there should be a high probability, say 1-ß, of rejecting the test of H o : δ = 0. The quantity δ 0 is often called the minimal (clinically) relevant treatment effect. The quantity 1-ß represents the degree of certainty with which the treatment effect δ 0 would be detected, and is called the power to detect a difference of magnitude δ 0 . The quantity ß, commonly called the type II error, is the probability of not detecting a significant treatment effect when there is a true treatment effect of magnitude δ 0 , i.e. ß is the risk of a false negative (FN) result. The foregoing is summarized in Table 1 . The relevant treatment effect is specified under the alternative hypothesis H 1 : δ ≥ δ 0 . This is a one-sided alternative hypothesis, to be tested with a one-sided value of α. A two-sided alternative hypothesis would be formulated as H 1 : |δ| ≥ δ 0 and would be tested with a twosided value of α.
When the outcome variable is continuous, its variability σ has to be specified, in addition to α, ß and δ 0 .
Based on these specifications and the statistical test to be used, the minimal number of patients that is needed can be calculated. Note that there is a very close relation between sample size calculation in the planning phase of a study and the statistical test used in the analysis phase.
In the sample size formulae the dependence on α and β is expressed mathematically by quantities Z α and Z ß . For an arbitrary number γ between 0 and 1, Zγ denotes the value such that a standard normal deviate has exactly the probability γ of exceeding that value. Table 2 gives the value of Zγ for some frequently used values of γ. 
One sample
For one group with a dichotomous outcome variable, the sample size n can be estimated The appropriate statistical test in this situation is a binomial test for one proportion.
Two samples
When two independent groups are to be compared with respect to a dichotomous variable, the sample size per group can be estimated by The sample size calculation above can also be applied when the null hypothesis and the alternative hypothesis are expressed in terms of a relative risk (RR). If p C was known or assumed to be known, then p E = RR x p C .
Some general remarks should be made with regard to the formula above. First, for the sample size estimation in studies with two samples we assume equal group sizes, which is the statistically most efficient design. Second, the sample size is inversely proportional to δ 0 2 , which means that, for fixed α and ß, halving the difference in success rates will require about a fourfold increase in the group size. Third, the factor p(1-p) is related to the variance of a dichotomous outcome variable. The variability is highest for p=0.5 and decreases if p tends to 0 or 1. Since p(1-p) is thus always smaller than or equal to 0.25, an upper bound for the sample size can be given by the simpler formula This approximation can be very valuable in practice and is reasonably good when p does not differ greatly from 0.5 (0.3 < p < 0.7).
The appropriate statistical test in this situation is a chi-square test for the comparison of two proportions.
'Equivalence' in two samples
The sample size formulae given in section 3.2 cannot be applied when 'equivalence' is to be detected between two groups with respect to the dichotomous outcome variable. Real equivalence of two groups can never be concluded based on two samples, but one can specify the maximal difference δ 0 in the outcome variable for which the two treatments can be considered equivalent. Then the sample size per group can be estimated by
with p = the 'success' rate of both treatments (p = p E = p C ). 
If a difference of 10% is too large for 'equivalence' and 5% is considered more appropriate, the number of patients per group becomes at least 1005.

It is clear that 'true' equivalence requires a large number of subjects.
One should realize that in the equivalence situation described above, the roles of the null and the alternative hypothesis have, in fact, changed. Now the null hypothesis is formulated as "the two treatments differ by an amount of at least δ 0 ", while the alternative hypothesis becomes "the two treatments can be considered equivalent," or "the two treatments differ by an amount of at most δ 0 ". Also the roles of α and β are reversed and they must be chosen with some thought. However, the impact of this on sample size may not be very large.
Paired samples
When two observations are made on the same individuals, these observations cannot be assumed to be independent of each other. The statistical test and the sample size estimation will have to take into account this dependency. Only the combinations 2 and 3 are informative, however, for a possible difference between the two observations. For a sample of individuals the results can be summarized as in Table 3 . The expected difference can be expressed as a fraction of the total number of individuals with combination 2 or 3 or as an odds ratio (OR). The total number of informative pairs is equal to r + s = n. The OR is defined as r/s.
The necessary number of individuals with combination 2 or 3 can be estimated by 
The expected difference between the two observations can also be expressed as a fraction r/n. Under the null hypothesis this fraction is assumed to equal 0.5. An OR of 2 corresponds to a fraction r/n of 0.667. For the example this means that test A is positive and test B is negative in two-thirds of the total number of informative individuals.
The appropriate statistical test in this situation is McNemar's test.
Continuous outcome
In this section we assume that the continuous outcome variable follows a normal distribution. A normal distribution is characterized by a mean µ and a standard deviation σ.
The standard deviation σ is almost always unknown in practice. It must be estimated by a value s derived from one's previous research or from the literature.
One sample
The sample size necessary to detect a difference δ 0 in a normally distributed outcome variable can be estimated by The appropriate statistical test in this situation is a one-sample t-test.
It must be noted that the sample size estimation uses Z-values, derived from a normal distribution. But, because we substitute an estimated value s for the standard deviation σ, the statistical test is based on a t-distribution instead of the normal distribution. Thus, instead of the Z-values t-values should be used. These t-values depend on 'degrees of freedom'. Here the corresponding number of degrees of freedom is n-1. For large samples (n > 100) there is little difference between Z-values and t-values. For smaller samples the sample size n must be estimated iteratively using the appropriate t-values.
Example revisited:
The number of degrees of freedom (d.f.) 
Two samples
When two samples are to be compared with respect to their means, we make two assumptions. First, we assume that the outcome variable follows a normal distribution.
Second, we assume that the population standard deviations in the two groups are equal.
Again the unknown (common) standard deviation σ is replaced by an estimate s. To detect a difference between the means of the two groups the sample size per group can be estimated by Example:
In a biological experimental design the leaf production velocity (a measure for the regeneration of the tropical forest) in the dry season is compared to that in the wet season.
In 
'Equivalence' in two samples
To investigate 'equivalence' of two samples with respect to the mean of a continuous outcome variable the same formula and iterative process can be used as described in section 4.2. The same remarks can be made here as in the case with a dichotomous outcome (section 3.3).
Paired samples
When two observations are made on the same individuals, these observations cannot be assumed to be independent of each other; the statistical test and the sample size estimation will have to take into account this dependency. For a continuous outcome variable, the differences between the two observations per individual form the sample for the statistical analysis. Because of this we can use the sample size formula as given in 4.1 for one sample: The appropriate statistical test is a t-test for paired samples. Again, as in the one-and twosample design t-values should be used instead of Z-values leading again to an iterative process for determining the required sample size.
Note that s d is not the same as s in the sample size formula for one sample. s d is the standard deviation of the differences and depends on the correlation between the observation before and the observation after the intervention. When only the variance s² of the observations is known, the variance s d 2 of the differences can be estimated using the formula s d 2 = 2s² (1-ρ), where ρ is the correlation between the observations. If ρ = 0 (no correlation), the observations before and after are in fact two independent samples, each with variance s². When ρ = 1 (perfect correlation), the differences have no variance. In practice, some value between 0 and 1 should be assumed, for example 0.2 when little correlation between the observations is expected, 0.8 when a large correlation is expected, or 0.5 if moderate correlation is expected.
If the correlation between the observations is large, the gain in efficiency from using a paired design and analysis is large compared to a design with two independent samples.
Survival outcome
Two samples
In this section the outcome variable is a time-to-event, for example when people are followed until death. In practice, not everyone can be observed until death; some people will die during the study, while others can be followed until the end of the study period. If these individuals are still alive at the end of the study, we call their observed follow-up times 'censored'. Thus the length of follow-up may vary between individuals and the outcome is dichotomous (event 'yes' or 'no'). To compare two groups of individuals with respect to their follow-up times on two different treatments (for example a control treatment C and an experimental treatment E), a log-rank test is used. The power of the log-rank test depends on the total number of events in the study, rather than on the number of individuals enrolled in the study. Therefore sample size and study duration are 
6
Cohen's effect size
The sample size calculations discussed in the previous sections depend on assumed values for e.g. the standard deviation of the outcome variable, the 'success' probability of the control treatment, etc. Especially in pilot studies this information is not always available from previous investigations or from literature. Despite this lack of information it still is a matter of Good Statistical Practice to make an educated guess of the sample size needed for one's study. For this purpose Cohen (1988 Cohen ( ,1992 introduced the concept of 'Effect Size' (ES) . Each statistical test has its own ES index. All these indexes are dimensionless and continuous, ranging upward from zero. For all tests, the null hypothesis is that ES=0.
Cohen proposed for each ES index the operational definitions 'small', 'medium' and 'large', which are approximately consistent across the different ES indexes.
For the comparison of two groups, whether the outcome variable is continuous or dichotomous, a small ES is about 0.2, a medium ES corresponds to a value of about 0.5
and a large ES is about 0.8.
Note that in the following we revisit the examples just for illustrational purposes with the given or assumed values for the important parameters, such as the standard deviation or the response rate in the control group. In practice, an assumption only has to be made for the ES index, be it small, medium or large.
Two samples with a dichotomous outcome variable
For a difference between two proportions p C and p E the ES index is defined as |φ E -φ C | with φ = 2 arcsin √p. In practice this ES index is approximately equal to 2| p E -p C |.
The number of patients per group can be estimated using 
6.2
One sample with a dichotomous outcome variable
For this situation the same formula for the ES index can be applied as given in section 6.1
with p E equal to p 1 , the rate under the alternative hypothesis and p c equal to p 0 , the rate under the null hypothesis.
The sample size can be estimated using 
One sample with a continuous outcome or with paired observations
The ES index is defined in this case as δ 0 / σ for one sample and as δ d / σ d for paired observations. The sample size can again be estimated using 
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Sequential alternatives Ludbrook (2003) The first step in the process of determining the sample size of a study is usually the application of one of the sample size formulae of the previous sections. The resulting sample size provides a preliminary idea of the general order of magnitude that is needed.
It is important to realize that sample size calculations will always be approximate. For example, the numbers resulting from the formulae are rather sensitive to misspecifications of the standard deviation of a continuous outcome variable or the incidence rate in the control group. In practice, often only poor estimates for these quantities are available.
The determination of sample size required in the comparison of more than two treatment groups is much more complicated than in the case of two groups. Greenland (1985) describes a general method that can be used if the outcome variable is dichotomous or polytomous, and the χ²-test is used on multi-way contingency tables.
Fleiss (1986) discusses the case that the outcome is continuous and one-way analysis of variance is used for testing the treatment effects.
If in the end the calculated sample size needed to detect relevant effect sizes is larger than is feasible, one should consider abandoning the study before it starts. This will avoid wasting money, time, efforts, etc. in a scientifically inadequate study.
It is a matter of Good Statistical Practice to estimate the minimal group size at the design phase of an experimental study. Quite rightly, institutional human and animal ethics committees insist on this.
Biostatistics can help with sample size estimation, but the investigator will have to provide necessary information. This information can be based on earlier studies in the same institute or laboratory or on published literature.
The important thing is to be realistic in one's expectations. Expectation of large effect sizes may lead to feasibly small sample sizes, but a too small sample size is unethical.
